000813 德展健康
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)-0.3221.582-0.880-1.0224.940
总资产报酬率 ROA (%)-0.3131.507-0.820-0.9464.617
投入资产回报率 ROIC (%)-0.3191.565-0.868-1.0104.750

边际利润分析
销售毛利率 (%)51.57458.73555.48666.97669.625
营业利润率 (%)-16.41816.106-20.815-5.06436.608
息税前利润/营业总收入 (%)-33.9803.387-31.629-11.45434.433
净利润/营业总收入 (%)-21.34710.890-26.882-13.09828.419

收益指标分析
经营活动净收益/利润总额(%)30.10236.407-7.227-308.23972.603
价值变动净收益/利润总额(%)10.15298.131-15.853-86.48627.330
营业外收支净额/利润总额(%)4.9311.9761.867-0.225-0.924

偿债能力分析
流动比率 (X)31.23636.40911.82114.24411.620
速动比率 (X)29.46334.27411.07213.04510.862
资产负债率 (%)2.8162.5506.9095.3316.975
带息债务/全部投入资本 (%)0.038-0.0780.3910.388--
股东权益/带息债务 (%)259,860.666-127,036.02425,175.13825,422.88135,856.259
股东权益/负债合计 (%)3,455.7743,819.2371,349.6031,743.8911,321.202
利息保障倍数 (X)2.033-0.2603.0361.789-18.715

营运能力分析
应收账款周转天数 (天)129.541172.701205.925144.7600.000
存货周转天数 (天)374.257401.493390.241454.8960.000